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Introduction: Smoking during pregnancy has been associated with miscarriage, placenta 
abruption, placenta praevia, low birth weight and perinatal mortality. In the long-term, 
maternal smoking during pregnancy appears to increase the probability of respiratory 
disorders, obesity and behavioral problems1. Cigarette smoke contains two main compounds: 
carbon monoxide and nicotine; both cross the placenta into the fetus where they reach levels 
exceeding those found in the maternal circulation2. This work studies the effects of maternal 
smoking on the growth of different fetal organs and the placenta. Aim: To investigate the effect 
of maternal smoking on the growth of the fetal lungs, kidneys, liver, brain and placenta.  
Methods: Scanning: Following approval by the ethics committee, we recruited 18 healthy 
pregnant women from Queen’s Medical Centre Nottingham: 10 current smokers and 8 non-
smokers matched for age, parity, BMI and education level; all gave informed consent to 
participate in the study. Pregnant women’s self-reported smoking habits were recorded. 
Pregnant women were scanned twice: Visit 1 (22–27 weeks of gestational age [GA]) and Visit 2 
(33–38 GA) using 1.5 T Philips Achieva MRI scanner with 5-element SENSE cardiac coil or 4-
element SENSE torso coil, depending on the woman’s size. Women lay on their right side in the 
decubitus position to avoid compression of the vena cava. All scans were conducted with a 
specific absorption rate of <2.0 W kg-1. Three sequences were acquired to study fetal growth: (1) Half Fourier Single Shot Turbo Spin-Echo 
for the whole body (HASTEbody, 123 slices in 147 seconds, TE = 120 ms and 0.78×0.78×6.00 mm3 voxels); (2) high resolution HASTE to 
study the brain (HASTEbrain, 34 slices in 35.8 seconds, TE = 120 ms and 0.59×0.59×4.50 mm3 voxels); and (3) Balanced Fast Field Echo for 
the abdominal organs (bFFE, 130 slices in 167 seconds, TR = 5.8 ms, TE = 2.3 ms, flip angle = 70° and 0.78×0.78×6.00 mm3 voxels). All 
sequences were acquired in three orthogonal blocks of images and without a breath hold to allow for motion effects to be averaged out. 
Analysis: The volume of the fetal kidneys and lungs were measured on at least two sets of images using a semi automatic segmentation 
method based on edge detection (Analyze 9.0). These were generally HASTEbrain for lung and bFFE for kidney; HASTEbody was used if 
these sets of data were seriously affected by artefact (generally motion or image non-uniformity artefacts). Volumes of the fetal liver and 
fetal brain were measured on three orientations of HASTE images using the Cavalieri method in combination with point counting3,4 using 
EasyMeasure software5. Measurements for each organ were averaged; the individual measurements varied by approximately 0–10% of the 
mean across all fetuses. The total fetal volume was measured by drawing a freehand mask around the fetus using Analyze 9.0.  
Results: The effect of exposure on the volume of fetal organs was assessed using a mixed model ANCOVA. Each independent analysis of the 
six organs included one within-subject variable (Visit) and one between-subject variable (Exposure). Four covariates were included in all 
analyses: maternal education, gestational age at visit 1, the difference in gestational age between visit 1 and 2, and fetal sex. For lung volume, 
a significant effect of Exposure was found [F(1,12) = 7.544, p < 0.05] with exposed fetuses showing lower lung volume than non-exposed 
controls across both Visits. For kidney volume, there is a significant interaction between Exposure and Visit [F(1,12) = 20.857, p < 0.01], with 
exposed fetuses showing lower kidney volume compared with non-exposed fetuses at Visit 1 (p < 0.05; Cohen’s d = 1.6) and Visit 2 
(p < 0.001; d = 1.9). For brain volume, exposed fetuses showed significantly lower brain volume than non-exposed controls at Visit 2 
(p < 0.05; d = 1.0) but not at Visit 1 (d = 0.1); Exposure by Visit interaction approached significance (F(1,12) = 3.676, p = 0.079). The liver 
volume did not show a statistically significant effect due to exposure. There is a significant interaction between Exposure and Visit for total 
fetal volume [F(1,12) = 9.507, p < 0.01]. Post-hoc comparisons revealed that exposed fetuses showed lower total volume compared with non-
exposed controls at Visit 1 (p < 0.01; d = 1.8) and Visit 2 (p < 0.01; d = 2.1). For fetal placenta volume, a significant effect of Exposure was 
found [F(1,12) = 6.874, p < 0.05] with exposed fetuses showing lower placenta volume than non-exposed controls across both visits 
(Visit 1: d = 0.88; Visit 2: d = 0.37). 
Discussion: Fetal lung, kidney and 
brain volumes are reduced by 
maternal smoking during 
pregnancy; late in pregnancy (33–
38 GA), the group differences are 
of large effect sizes, with Cohen’s d 
values equaling 0.36 (placenta), 
1.0 (brain), 1.9 (kidneys) and 2.1 
(total fetal volume).  
Conclusions: Maternal smoking 
during pregnancy reduces growth 
in all organs measured except the 
liver.  
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Figure 1: MRI (bFFE sequences) : Sagittal 
plane through fetus; K = Kidney, L = lung,   
LV = liver, B = brain and P = placenta 
Figure 2: Effect of maternal smoking on fetal brain, lungs, liver, kidneys, placenta and total fetal volume.
